James Paul Scopa Insider Profile

4 Followers
James Paul Scopa, Director at Trivascular Technologies, holds 103.33K shares in Adverum Biotechnologies (Ticker: ADVM), holds 183.08K shares in Aligos Therapeutics (Ticker: ALGS), holds 0.00 shares in Dice Therapeutics (Ticker: DICE). Most recently, James Paul Scopa Bought ― shares of Adverum Biotechnologies on Feb 09, 2024 for an estimated value of 135.00K.
tipranks
James Paul Scopa

James Paul Scopa
Trivascular Technologies (TRIV)
Director

Ranked #12,616 out of 98,990 Corporate Insiders

Profitable Transactions

40%
2 out of 5 Profitable Transactions

Average Return

+30.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3M
59.03%
30.75%
10.22%
A breakdown of James Paul Scopa's holdings

Insider Roles

Aligos Therapeutics
(ALGS)
Director
Adverum Biotechnologies
(ADVM)
Director
Histogen
(HSTO)
Director
Roles that James Paul Scopa holds in companies

Most Profitable Insider Trade

Stock:
Adverum Biotechnologies
(ADVM)
Rating:Informative Buy
Date:May 06, 2019 - May 06, 2020
Return:+204.70%
The most profitable trade made by James Paul Scopa

James Paul Scopa's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
TRIV
Trivascular Technologies
Feb 04, 2016
Uninformative Sell
$0.00
Adverum Biotechnologies
Feb 09, 2024
Director
Informative Buy
135.00K
$778.11K
Aligos Therapeutics
Oct 27, 2023
Director
Uninformative Buy
137.31K
$1.49M
DICE
Dice Therapeutics
Aug 09, 2023
Uninformative Sell
$0.00
Histogen
Aug 01, 2013
Director
Uninformative Buy
183.88K
$258.68K
List of latest transactions for each holding click on a transaction to see James Paul Scopa's performance on stock

James Paul Scopa insider profile FAQ

What is the percentage of profitable transactions made by James Paul Scopa?
The percentage of profitable transactions made by James Paul Scopa is 40%.
    What is the average return per transaction made by James Paul Scopa?
    The average return per transaction made by James Paul Scopa is 30.80%.
      What stocks does James Paul Scopa hold?
      James Paul Scopa holds: TRIV, ADVM, ALGS, DICE, HSTO stocks.
        What was James Paul Scopa’s latest transaction?
        James Paul Scopa latest transaction was an Informative Buy of $135.00K.
          What was James Paul Scopa's most profitable transaction?
          James Paul Scopa’s most profitable transaction was an Informative Buy of ADVM stock on May 6, 2019. The return on the trade was 204.70%.
            What is James Paul Scopa's role in Trivascular Technologies?
            James Paul Scopa's role in Trivascular Technologies is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.